ENTITY
Exelixis Inc

Exelixis Inc (EXEL US)

16
Analysis
Health CareUnited States
Exelixis, Inc. is a development-stage biotechnology company dedicated to the discovery and development of small-molecule therapeutics for the treatment of cancer and other serious diseases. The Company is building a portfolio of compounds it believes could become pharmaceutical products. Exelixis has strategic alliances with pharmaceutical and biotechnology companies.
more
Company Event07 Feb 2025 05:00 • Upcoming
Add To Calendar
Company Event30 Oct 2024 05:00 • Latest
Company Event07 Aug 2024 05:00
Company Event01 May 2024 05:00
Company Event07 Feb 2024 06:00
x